Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
The Biochemical Journal|January 1, 1979
6 beta-Bromopenicillanic acid inactivates beta-lactamase IV Knott-Hunziker, B S Orlek, P G Sammes, et al.Protein Engineering|May 30, 1998
A molecular mechanism for toxin block in N-type calcium channelsS W Doughty, F E Blaney, B S Orlek, et al.The Biochemical Journal|June 1, 1980
Kinetics of inactivation of beta-lactamase I by 6 beta-bromopenicillanic acidV Knott-Hunziker, B S Orlek, P G Sammes, et al.Journal of Medicinal Chemistry|June 26, 1992
Substituent variation in azabicyclic triazole- and tetrazole-based muscarinic receptor ligandsS M Jenkins, H J Wadsworth, S Bromidge, et al.The Journal of Pharmacology and Experimental Therapeutics|February 12, 1998
SB 202026: a novel muscarinic partial agonist with functional selectivity for M1 receptorsJ M Loudon, S M Bromidge, F Brown, et al.Journal of Medicinal Chemistry|April 3, 1992
Synthesis and muscarinic activities of quinuclidin-3-yltriazole and -tetrazole derivativesH J Wadsworth, S M Jenkins, B S Orlek, et al.Journal of Medicinal Chemistry|September 1, 1991
Comparison of azabicyclic esters and oxadiazoles as ligands for the muscarinic receptorB S Orlek, F E Blaney, F Brown, et al.Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Identification of a series of 1,2,3,4-tetrahydroisoquinolinyl-benzamides with potential anticonvulsant activityW N Chan, M S Hadley, J D Harling, et al.Journal of Medicinal Chemistry|January 22, 1998
Design of [R-(Z)]-(+)-alpha-(methoxyimino)-1-azabicyclo[2.2.2]octane-3-acetonitri le (SB 202026), a functionally selective azabicyclic muscarinic M1 agonist incorporating the N-methoxy imidoyl nitrile group as a novel ester bioisostereS M Bromidge, F Brown, F Cassidy, et al.Bioorganic & Medicinal Chemistry|September 26, 2000
Evaluation of a series of anticonvulsant 1,2,3,4-tetrahydroisoquinolinyl-benzamidesW N Chan, M S Hadley, J D Harling, et al.Pageof 2